New data show benefits of ICM use to detect AF after non-cardioembolic stroke

Using insertable cardiac monitoring (ICM) devices in patients with ischemic stroke attributed to small vessel occlusion (SVO) or large artery atherosclerosis (LAA) can help detect post-stroke atrial fibrillation (AF) and inform prevention strategies, specialists reported at ISC 2021.

Dr Lee Schwamm from Massachusetts General Hospital in Boston, USA, presented 1-year data from the ongoing Stroke AF trial.

The aim of this prospective 33-center study is to establish rates of AF in patients with stroke etiology of SVO or LAA, comparing continuous monitoring with an ICM with the center-specific standard of care (SOC) for detection of cardiac arrhythmias.